Does BISOPROLOL Cause Bronchial secretion retention? 163 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 163 reports of Bronchial secretion retention have been filed in association with BISOPROLOL (bisoprolol fumarate and hydrochlorothiazide). This represents 0.6% of all adverse event reports for BISOPROLOL.
163
Reports of Bronchial secretion retention with BISOPROLOL
0.6%
of all BISOPROLOL reports
0
Deaths
160
Hospitalizations
How Dangerous Is Bronchial secretion retention From BISOPROLOL?
Of the 163 reports, 160 (98.2%) required hospitalization, and 53 (32.5%) were considered life-threatening.
Is Bronchial secretion retention Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BISOPROLOL. However, 163 reports have been filed with the FAERS database.
What Other Side Effects Does BISOPROLOL Cause?
Dyspnoea (2,940)
Bradycardia (2,535)
Hypotension (2,504)
Dizziness (2,153)
Fall (2,011)
Fatigue (1,983)
Acute kidney injury (1,894)
Malaise (1,602)
Drug ineffective (1,486)
Nausea (1,460)
What Other Drugs Cause Bronchial secretion retention?
ALBUTEROL (374)
TIOTROPIUM (295)
PREDNISONE (268)
MONTELUKAST (240)
MEPOLIZUMAB (209)
BUDESONIDE (182)
OMALIZUMAB (171)
FUROSEMIDE (169)
BUDESONIDE\FORMOTEROL (156)
ACETAMINOPHEN (151)
Which BISOPROLOL Alternatives Have Lower Bronchial secretion retention Risk?
BISOPROLOL vs BISOPROLOL\BISOPROLOL
BISOPROLOL vs BISOPROLOL\HYDROCHLOROTHIAZIDE
BISOPROLOL vs BIVALIRUDIN
BISOPROLOL vs BLEOMYCIN
BISOPROLOL vs BLINATUMOMAB